Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
4
×
indiana blog main
4
×
indiana top stories
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
national
bristol-myers squibb
cancer
eli lilly
immunotherapy
loxo oncology
merck
pfizer
roche
san francisco
a2 biotherapeutics
acquisition
What
time
4
×
approved
days
drug
fda
agency
aimmune
airport
allergy
alliance
annual
apocalypse
approval
awarded
beds
bio
bristol
buy
calls
cancer
celgene
changing
color
crispr
deeper
developed
dna
fallout
fingerprint
friday
genetic
going
gone
growing
home
hours
immunotherapy
j.p
jpm
kudos
Language
unset
Current search:
time
×
fda
×
" indiana blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
